CD27L-ANTIGEN-BINDENDE PROTEINE

Patent europeic · EP2758437 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2758437
Numer da la dumonda
EP12766835
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-09-2012
Publitgà
30-07-2014
Concedì
03-06-2020
La protecziun finescha il pli tard
19-09-2032
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
Prioritad
US 201161538024 P 22.09.2011
Dumonda PCT
PCT/US2012/056429 20.09.2012
Publicaziun PCT
WO2013/043933 28.03.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  4. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  5. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  6. 03-06-2020

    Concedì

    Published in Swissreg on 03.06.2020

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventur

DELANEY, John M.

Bellevue, WA 98004, US

KING, Chadwick Terence

North Vancouver, British Columbia V7L 3T5, CA

FANSLOW, William Christian, III

Normandy Park, WA 98166, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.